{"id":"W3199546106","doi":"10.1016/s1474-4422(21)00242-8","title":"Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial","year":2021,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"National Institute for Health and Care Research; OMRON Corporation","keywords":"Medicine; Amyotrophic lateral sclerosis; Clinical endpoint; Placebo; Levosimendan; Adverse effect; Population; Internal medicine; Physical therapy; Riluzole; Clinical trial; Heart failure; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002250062,0.001162783,0.003032426,0.000202177,0.0005328981,0.001055658,0.0006483365,0.004561296,0.005178357],"category_scores_gemma":[0.00455304,0.0004487864,0.001646847,0.0002362453,0.0007835881,0.001017784,0.000328207,0.0034806,0.00127663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006298205,"about_ca_system_score_gemma":0.0009136617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000896471,"about_ca_topic_score_gemma":0.001904041,"domain_scores_codex":[0.9992039,0.0004944477,0.0000687893,0.00008319443,0.00006826433,0.00008139591],"domain_scores_gemma":[0.9985011,0.0007985272,0.0002590517,0.00006682834,0.0001195479,0.0002551228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9480659,0.001180952,0.001324878,0.002526279,0.002109156,0.0002990096,0.000107128,0.0001349725,0.001270007,0.0002648153,0.01057919,0.03213763],"study_design_scores_gemma":[0.9751647,0.01622992,0.002601761,0.0002359436,0.001233238,0.00008668868,0.00005343369,0.0001978107,0.0002651197,0.0004138412,0.003494029,0.00002352353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.862446,0.06849136,0.001085259,0.03569883,0.01069341,0.002704256,0.004716847,0.0002615634,0.01390252],"genre_scores_gemma":[0.9279163,0.01559155,0.001612094,0.03419521,0.005222402,0.003369856,0.00188071,0.0000471261,0.01016469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005178357,"threshold_uncertainty_score":0.01732337,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08461749481689211,"score_gpt":0.3404554619137068,"score_spread":0.2558379670968147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}